Figure 1‑1: Soft Tissue Repair Market Share Ranking by Segment, U.S., 2021 |
Figure 1‑2: Companies Researched in this Report |
Figure 1‑3: Factors Impacting the Soft Tissue Repair Market by Segment, U.S. |
Figure 1‑4: Recent Events in the Soft Tissue Repair Market, U.S., 2018 – 2022 (1 of 2) |
Figure 1‑5: Recent Events in the Soft Tissue Repair Market, U.S., 2018– 2022 (2 of 2) |
Figure 1‑6: Soft Tissue Repair Procedures Covered (1 of 2) |
Figure 1‑7: Soft Tissue Repair Procedures Covered (2 of 2) |
Figure 1‑8: Procedure Codes Investigated |
Figure 1‑9: Soft Tissue Repair Markets Covered (1 of 3) |
Figure 1‑10: Soft Tissue Repair Markets Covered (2 of 3) |
Figure 1‑11: Soft Tissue Repair Markets Covered (3 of 3) |
Figure 1‑12: Key Report Updates |
Figure 1‑13: Version History |
Figure 2‑1: Soft Tissue Repair Market by Segment, Worst Case Scenario, U.S., 2018 – 2028 (US$M) |
Figure 2‑2: Soft Tissue Repair Market by Segment, Base Case Scenario, U.S., 2018 – 2028 (US$M) |
Figure 2‑3: Soft Tissue Repair Market by Segment, Best Case Scenario, U.S., 2018 – 2028 (US$M) |
Figure 4‑1: Breast Reconstruction Products Market by Company |
Figure 4‑2: Hernia Repair Market Products by Company (1 of 2) |
Figure 4‑3: Hernia Repair Market Products by Company (2 of 2) |
Figure 4‑4: Dural Repair Market Products by Company |
Figure 4‑5: Dental Soft Tissue Regeneration Market by Company |
Figure 4‑6: Nerve Repair Market by Company |
Figure 4‑7: Cardiovascular Repair Market by Company |
Figure 4‑8: Class 2 Device Recall VERITAS Collagen Matrix |
Figure 4‑9: Class 2 Device Recall Proceed Surgical Mesh |
Figure 4‑10: Class 2 Device Recall Gentrix Surgical Matrix Thick |
Figure 4‑11: Class 2 Device Recall DuraMatrix Collagen Dura Substitute Membranes |
Figure 4‑12: Class 2 Device Recall DuraMatrix Collagen Dura Substitute Membranes |
Figure 4‑13: Class 2 Device Recall CryoPatch SG Pulmonary Human Cardiac Patch |
Figure 4‑14: Evaluation of ADM Soft Tissue Reinforcement |
Figure 4‑15: Biosynthetic Absorbable Mesh vs Standard of Repair for the Surgical Treatment of Infected Incisional Hernia (COMpACT-BIO) |
Figure 4‑16: Mesh Type in Ventral Hernia Repair |
Figure 4‑17: Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair (PPDS) |
Figure 4‑18: A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair |
Figure 4‑19: Clinical Study on the Safety of SAFIL® MESH |
Figure 4‑20: Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias (ventral hernia) |
Figure 4‑21: A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. |
Figure 4‑22: To Compare Different Soft Tissue Grafts at the Time of Lateral Ridge Augmentation Procedure |
Figure 4‑23 TISSIUM™ Nerve Coaptation Device First-in-Human Clinical Trial: |
Figure 4‑24: Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair (RECON) |
Figure 4‑25: Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction (RANGER®) |
Figure 5‑1: Soft Tissue Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 5‑2: Leading Competitors, Soft Tissue Repair Market, U.S., 2021 |
Figure 5‑3: SWOT Analysis, Axogen |
Figure 5‑4: SWOT Analysis, AbbVie |
Figure 5‑5: SWOT Analysis, Artivion |
Figure 5‑6: SWOT Analysis, Becton Dickinson |
Figure 5‑7: SWOT Analysis, DePuy Synthes |
Figure 5‑8: SWOT Analysis, Ethicon |
Figure 5‑9: SWOT Analysis, W.L. Gore |
Figure 5‑10: SWOT Analysis, Integra LifeSciences |
Figure 5‑11: SWOT Analysis, LeMaitre Vascular |
Figure 5‑12: SWOT Analysis, Medtronic |
Figure 5‑13: SWOT Analysis, MTF Biologics |
Figure 5‑14: SWOT Analysis, Stryker |
Figure 5‑15: SWOT Analysis, Zimmer Biomet (ZimVie) |
Figure 6‑1: Procedure Codes Investigated, U.S., 2021 |
Figure 6‑2: Soft Tissue Repair Procedures by Segment, U.S., 2018 – 2028 |
Figure 6‑3: Breast Reconstruction Procedures by Method, U.S., 2018 – 2028 |
Figure 6‑4: Implant-Based Breast Reconstruction Procedures by Method, U.S., 2018 – 2028 |
Figure 6‑5: Implant-Based Breast Reconstruction Procedures by Timing, U.S., 2018 – 2028 |
Figure 6‑6: Implant-Based Breast Reconstruction Procedures by Type, U.S., 2018 – 2028 |
Figure 6‑7: Implant-Based Breast Reconstruction Procedures by Type, U.S., 2018 – 2028 |
Figure 6‑8: Implant-Based Breast Reconstruction Procedures by Devices Used, U.S., 2018 – 2028 |
Figure 6‑9: Autologous Breast Reconstruction Procedures by Timing, U.S., 2018 – 2028 |
Figure 6‑10: Autologous Breast Reconstruction Procedures by Type, U.S., 2018 – 2028 |
Figure 6‑11: Breast Reconstruction Procedures by Care Setting, U.S., 2018 – 2028 |
Figure 6‑12: Hernia Repair Procedures by Type, U.S., 2018 – 2028 |
Figure 6‑13: Hernia Repair Procedures by Care Setting, U.S., 2018 – 2028 |
Figure 6‑14: Hernia Repair Procedures by Robotic Assistance, U.S., 2018 – 2028 |
Figure 6‑15: Dural Repair Procedures by Care Setting, U.S., 2018 – 2028 |
Figure 6‑16: Dental Soft Tissue Procedures, U.S., 2018 – 2028 |
Figure 6‑17: Cardiovascular Patch Repair Procedures, U.S., 2018 – 2028 |
Figure 6‑18: Nerve Repair Procedures by Care Setting, U.S., 2018 – 2028 |
Figure 7‑1: Breast Reconstruction Market by Material Type, U.S., 2018 – 2028 (US$M) |
Figure 7‑2: Breast Reconstruction Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 7‑3: Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑4: Allograft Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑5: Xenograft Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑6: Synthetic Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑7: Hospital Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑8: Non-Hospital Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑9: Leading Competitors, Breast Reconstruction Market, U.S., 2021 |
Figure 8‑1: Hernia Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 8‑2: Hernia Repair Market by Material, U.S., 2018 – 2028 (US$M) |
Figure 8‑3: Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑4: Ventral Hernia Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 8‑5: Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑6: Allograft Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑7: Xenograft Ventral Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Figure 8‑8: Xenograft Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑9: Reinforced Xenograft Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑10: Non-Reinforced Xenograft Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑11: Synthetic Ventral Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Figure 8‑12: Synthetic Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑13: Resorbable Synthetic Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑14: Non-Resorbable Synthetic Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑15: Ventral Hernia Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 8‑16: Hospital Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑17: Non-Hospital Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑18: Inguinal Hernia Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 8‑19: Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑20: Allograft Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑21: Xenograft Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑22: Synthetic Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑23: Inguinal Hernia Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 8‑24: Hospital Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑25: Non-Hospital Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑26: Hiatal Hernia Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 8‑27: Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑28: Allograft Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑29: Xenograft Hiatal Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Figure 8‑30: Xenograft Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑31: Reinforced Xenograft Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑32: Non-Reinforced Xenograft Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑33: Synthetic Hiatal Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Figure 8‑34: Synthetic Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑35: Resorbable Synthetic Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑36: Non-Resorbable Synthetic Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑37: Hiatal Hernia Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 8‑38: Hospital Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑39: Non-Hospital Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑40: Leading Competitors, Hernia Repair Market, U.S., 2021 |
Figure 9‑1: Dural Repair Market by Material Type, U.S., 2018 – 2028 (US$M) |
Figure 9‑2: Dural Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 9‑3: Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑4: Allograft Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑5: Xenograft Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑6: Synthetic Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑7: Hospital Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑8: Non-Hospital Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑9: Leading Competitors, Dural Repair Market, U.S., 2021 |
Figure 10‑1: Dental Soft Tissue Regeneration Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 10‑2: Dental Soft Tissue Regeneration Market, U.S., 2018 – 2028 |
Figure 10‑3: Allograft Dental Soft Tissue Regeneration Market, U.S., 2018 – 2028 |
Figure 10‑4: Xenograft Dental Soft Tissue Regeneration Market, U.S., 2018 – 2028 |
Figure 10‑5: Dental Wound Care Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 10‑6: Dental Wound Care Market, U.S., 2018 – 2028 |
Figure 10‑7: Plug Dental Wound Care Market, U.S., 2018 – 2028 |
Figure 10‑8: Tape Dental Wound Care Market, U.S., 2018 – 2028 |
Figure 10‑9: Foam Dental Wound Care Market, U.S., 2018 – 2028 |
Figure 10‑10: Leading Competitors, Dental Soft Tissue Regeneration Market, U.S., 2021 |
Figure 11‑1: Nerve Repair Market by Product Type, U.S., 2018 – 2028 (US$M) |
Figure 11‑2: Nerve Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 11‑3: Nerve Repair Market, U.S., 2018 – 2028 |
Figure 11‑4: Nerve Wrap Market, U.S., 2018 – 2028 |
Figure 11‑5: Nerve Graft Market, U.S., 2018 – 2028 |
Figure 11‑6: Nerve Tube Market, U.S., 2018 – 2028 |
Figure 11‑7: Nerve Cap Market, U.S., 2018 – 2028 |
Figure 11‑8: Hospital Nerve Repair Market, U.S., 2018 – 2028 |
Figure 11‑9: Non-Hospital Nerve Repair Market, U.S., 2018 – 2028 |
Figure 11‑10: Leading Competitors, Nerve Repair Market, U.S., 2021 |
Figure 12‑1: Cardiovascular Patch Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 12‑2: Cardiovascular Patch Repair Market by Material, U.S., 2018 – 2028 (US$M) |
Figure 12‑3: Cardiovascular Patch Repair Market, U.S., 2018 – 2028 |
Figure 12‑4: Cardiac Patch Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 12‑5: Cardiac Patch Market, U.S., 2018 – 2028 |
Figure 12‑6: Allograft Cardiac Patch Market, U.S., 2018 – 2028 |
Figure 12‑7: Xenograft Cardiac Patch Market, U.S., 2018 – 2028 |
Figure 12‑8: Synthetic Cardiac Patch Market, U.S., 2018 – 2028 |
Figure 12‑9: Vascular Patch Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 12‑10: Vascular Patch Market, U.S., 2018 – 2028 |
Figure 12‑11: Xenograft Vascular Patch Market, U.S., 2018 – 2028 |
Figure 12‑12: Synthetic Vascular Patch Market, U.S., 2018 – 2028 |
Figure 12‑13: Leading Competitors, Cardiovascular Patch Repair Market, U.S., 2021 |
Figure 12‑14: Leading Competitors, Cardiac Patch Market by Material, U.S., 2021 |
Figure 12‑15: Leading Competitors, Vascular Patch Market by Material, U.S., 2021 |